Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Active Biotech and Oxigene enter inflammatory disease collaboration

June 17, 1999

Fujisawa develops antiinflammatory agents acting on cyclooxygenase

June 17, 1999

CPMP recommends approval of DMARD

June 16, 1999

Antiinflammatory and immunosuppressive compounds related to leflunomide

June 15, 1999

MMP and TNF-alpha inhibitors developed at Darwin Discovery

June 14, 1999

New Amgen compounds inhibit production of proinflammatory cytokines

June 14, 1999

Anika and Zimmer expand Orthovisc distribution agreement

June 14, 1999

ATTRACT trial demonstrates long-term efficacy and safety of Remicade in RA

June 11, 1999

Chinese herb provides significant benefit in mouse model of SLE

June 11, 1999

U.K. is first European country to approve Vioxx for marketing; U.S. introduction announced

June 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.